Suzanne Nguyen

Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) Study

Rosine Guimbaud, Christophe Louvet, Pauline Ries et al. · Journal of Clinical Oncology · 2014 · 256 citations

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Paul Cottu, Véronique D’Hondt, Sylvain Dureau et al. · Annals of Oncology · 2018 · 160 citations · Full text

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study

Cynthia Reichling, Valentin Dérangère, Quentin Klopfenstein et al. · Gut · 2019 · 121 citations · Full text

Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study

Thierry André, Hélène Blons, May Mabro et al. · Annals of Oncology · 2012 · 91 citations · Full text

Translational Molecular Study, Medicine, Standard Chemotherapy +10